Literature DB >> 16152625

DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients.

Coral V A Wynter1, Takeshi Kambara, Michael D Walsh, Barbara A Leggett, Joanne Young, Jeremy R Jass.   

Abstract

Colorectal adenomas have traditionally been regarded as homogeneous. The aim of our study was to identify molecular features that may differentiate sporadic adenomas from familial adenomas such as Familial Adenomatous Polyposis (FAP) and Multiple Adenoma patients. DNA methylation was tested at Methylated IN Tumor (MINT) loci (1,2,12,31) and the CpG promoter region of genes MLH1, HPP1, MGMT, p14ARF and p16INK4a in FAP-associated adenomas (33) from 5 patients with a known APC mutation (Group 1, FAP), adenomas (29) from 4 Multiple Adenoma patients (Group 2 Multiple), adenomas (14) from 3 patients with sporadic colorectal cancers showing high microsatellite instability (Group 3, MSI-H) and adenomas (16) from 7 patients, with sporadic colorectal cancers showing microsatellite stable or low level instability (Group 4, MSS/MSI-L). Aberrant Crypt Foci (ACFs), Hyperplastic Polyps (HPs) and cancers were also examined for methylation status as well as K-ras mutation. Multiple Adenoma patients were examined for germline polymorphisms in the base excision repair gene, MYH. The familial syndrome, FAP -associated adenomas showed a significantly low frequency of MINT methylation (15.5%,) compared to sporadic MSS/MSI-L-associated adenomas (35.5%). Group 3 (MSI-H) adenomas were different in that many showed serration and a high level of methylation (57.1%). Group 2, Multiple Adenoma cases, resembled sporadic MSS/MSI-L-associated adenomas. However the promoter regions of key genes, MGMT, p14ARF and p16INK4a were methylated to a greater extent than MINTs in both sporadic and familial adenomas. Genetic profiling of adenomas supports the concept that adenomas belonging to familial syndromes pursue a different pathway to tumorigenesis than their sporadic counterpar/ts from their earliest formation.

Entities:  

Mesh:

Year:  2006        PMID: 16152625     DOI: 10.1002/ijc.21363

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

Review 1.  Colorectal cancer: a model for epigenetic tumorigenesis.

Authors:  J J L Wong; N J Hawkins; R L Ward
Journal:  Gut       Date:  2006-07-13       Impact factor: 23.059

2.  Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study.

Authors:  Li-Shu Wang; Mark Arnold; Yi-Wen Huang; Christine Sardo; Claire Seguin; Edward Martin; Tim H-M Huang; Ken Riedl; Steven Schwartz; Wendy Frankel; Dennis Pearl; Yiqing Xu; John Winston; Guang-Yu Yang; Gary Stoner
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

3.  Case-control study of candidate gene methylation and adenomatous polyp formation.

Authors:  M Alexander; J B Burch; S E Steck; C-F Chen; T G Hurley; P Cavicchia; N Shivappa; J Guess; H Zhang; S D Youngstedt; K E Creek; S Lloyd; K Jones; J R Hébert
Journal:  Int J Colorectal Dis       Date:  2016-10-22       Impact factor: 2.571

4.  Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.

Authors:  Zhao-Hui Huang; Li-Hua Li; Fan Yang; Jin-Fu Wang
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

5.  Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma.

Authors:  Michiel F G de Maat; Norihiko Narita; Anne Benard; Tetsunori Yoshimura; Christine Kuo; Rob A E M Tollenaar; Noel F C C de Miranda; Roderick R Turner; Cornelis J H van de Velde; Hans Morreau; Dave S B Hoon
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

6.  Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.

Authors:  Dao-Rong Wang; Dong Tang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 7.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

Review 8.  Tumor suppressor genes in familial adenomatous polyposis.

Authors:  Nahal Eshghifar; Naser Farrokhi; Tahereh Naji; Mohammadreza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

9.  Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer.

Authors:  Michael J Wargovich; Vondina R Brown; Jay Morris
Journal:  Cancers (Basel)       Date:  2010-09-16       Impact factor: 6.639

10.  Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.

Authors:  Kiyoko Takane; Keisuke Matsusaka; Satoshi Ota; Masaki Fukuyo; Yao Yue; Motoi Nishimura; Eiji Sakai; Kazuyuki Matsushita; Hideaki Miyauchi; Hiroyuki Aburatani; Yukio Nakatani; Tadatoshi Takayama; Hisahiro Matsubara; Kiwamu Akagi; Atsushi Kaneda
Journal:  Oncotarget       Date:  2016-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.